An overview of the status of the nitrosoureas in other tumors

Cancer Chemother Rep 3. 1973 May;4(3):35-46.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / drug therapy
  • Alkylating Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy
  • Carcinoma / drug therapy
  • Carcinoma, Bronchogenic / drug therapy
  • Carmustine / therapeutic use*
  • Cyclohexanes / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Drug Therapy, Combination
  • Hodgkin Disease / drug therapy
  • Humans
  • Hydroxyurea / therapeutic use
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Myeloid / drug therapy
  • Lymphoma / drug therapy
  • Melanoma / drug therapy
  • Melphalan / therapeutic use
  • Multiple Myeloma / drug therapy
  • Nitrosourea Compounds / therapeutic use*
  • Prednisone / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Alkylating Agents
  • Antineoplastic Agents
  • Cyclohexanes
  • Nitrosourea Compounds
  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Melphalan
  • Carmustine
  • Prednisone
  • Hydroxyurea